Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. It shows potential in developing drugs that modulate signaling pathways involved in tumor growth and inflammation. Its structure allows for strong binding to specific enzyme active sites, enhancing selectivity and reducing off-target effects. Also explored in the development of neurodegenerative disease treatments due to its ability to cross the blood-brain barrier and interact with neural receptors.